Serena Ventures and Foresite fuel Midi Health’s $100M raise
Serena Ventures, the investment firm founded by tennis icon Serena Williams, has joined forces with healthcare investor Foresite Capital in a new $100 million funding round for women’s health unicorn Midi Health. The deal underscores growing investor conviction that midlife women’s care is a massive, underserved market in digital health.
Midi Health targets the midlife care gap
Midi Health is a virtual care platform focused on women navigating perimenopause, menopause and related hormonal transitions. By combining telemedicine, personalized treatment plans and insurance-covered services, the company aims to close a persistent gap in mainstream healthcare, where symptoms such as hot flashes, sleep disruption, mood changes and metabolic shifts are often underdiagnosed or minimized.
The fresh capital will enable Midi Health to expand its network of specialized clinicians, enhance its digital platform and deepen partnerships with employers and health plans. Investors see the company as a category leader in a space where demand is rising sharply as more women seek evidence-based, stigma‑free support.
Strategic investors double down on women’s health
For Serena Ventures, the investment aligns with its thesis of backing founders who address systemic gaps in access and equity. The firm has previously highlighted women’s health, financial inclusion and consumer technology as core focus areas. Foresite Capital, known for its bets on healthcare and life sciences, brings deep expertise in scaling data‑driven clinical platforms.
The participation of these high-profile funds is expected to help Midi Health accelerate product development, strengthen clinical research around midlife women’s health, and position itself as a long‑term partner to large employers seeking to improve benefits for female employees.
Women’s health emerges as a major digital health frontier
The funding round adds momentum to a broader wave of investment in women’s health and digital health solutions. Analysts note that midlife care, including menopause management, has historically attracted far less capital than fertility or maternal health, despite affecting hundreds of millions of women globally.
By reaching unicorn status and securing backing from investors such as Serena Ventures and Foresite Capital, Midi Health sends a clear signal that targeted, tech-enabled care for women in midlife is moving from niche to mainstream in the healthcare innovation landscape.